# Major Recall Alert: Risperdal 2 mg Tablet Recalled Due to Circulation of an Unauthorized and Unregistered Brand Formulation in Nigeria
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued an important recall alert concerning the unauthorized circulation of Risperdal 2 mg tablets in Nigeria. Manufactured by Johnson & Johnson, this brand formulation has been found to lack the proper registration and authorization required for sale and distribution in the country. Consumers, distributors, and healthcare professionals are urged to remain vigilant to ensure counterfeit or unauthorized pharmaceutical products do not infiltrate the supply chain.
## Why This Recall is Important
Unauthorized and unregistered medicines pose a significant threat to public health. The lack of approval from regulatory authorities, like NAFDAC, raises concerns about product safety, efficacy, and authenticity. Risperdal, a prescription medication commonly used to treat mental health conditions such as schizophrenia and bipolar disorder, must meet strict quality control guidelines to ensure its safety for patients. Unauthorized formulations could contain harmful substances, incorrect dosages, or reduced efficacy, compromising patient outcomes.
This recall highlights the importance of heightened awareness and adherence to regulatory processes in the pharmaceutical industry. It also underscores the critical need for consumers to verify the authenticity of medicines before purchase or use, particularly for life-impacting medications like Risperdal.
## Details of the Recall
The following summarized details cover the main aspects of the unauthorized Risperdal 2 mg tablet brand formulation recall in Nigeria:
- **Category**: Public health recall in Nigeria
- **Product**: Risperdal 2 mg tablet (Johnson & Johnson brand)
- **Recall Reason**: Circulation of an unregistered and unauthorized brand formulation
- **Date Announced**: October 31, 2023
To assist consumers in identifying the affected product, NAFDAC has published official images, which can be viewed [here](https://nafdac.gov.ng/wp-content/uploads/2026/01/3.jpg) and [here](https://nafdac.gov.ng/wp-content/uploads/2026/01/4.jpg). Stay updated by visiting the official NAFDAC source [here](https://nafdac.gov.ng/public-alert-no-03-2026-alert-on-the-circulation-of-an-unauthorized-and-unregistered-risperdal-2-mg-tablets-brand-formulation-in-nigeria/).
## What You Should Do
NAFDAC has outlined precautionary measures to protect public safety. Here’s what consumers, distributors, and healthcare professionals should do:
- **Verify Products**: Obtain medications only from authorized or licensed suppliers. Always check their authenticity and physical condition.
- **Report Issues**: If you suspect you have a counterfeit or unauthorized Risperdal product, report immediately to NAFDAC at their dedicated platform.
- **Avoid Purchases from Unauthorized Sources**: Refrain from buying medications from unverified street vendors or online marketplaces.
- **Stay Vigilant in the Supply Chain**: Distributors and retailers must take extra caution to prevent the importation, distribution, or sale of counterfeit products.
By following these steps, Nigerian consumers and suppliers can help reduce the risks attached to counterfeit medications while protecting their health.
## Stay Safe – Get Instant Recall Alerts
Your health and safety are a top priority. Staying informed about the latest medical recalls is essential to avoid harmful products and ensure you have access to high-quality, authorized medications. You can now stay ahead by using mobile apps that provide real-time alerts and updates about product recalls and public safety announcements.
**Download the NAFDAC App today to receive instant recall alerts and report suspicious or substandard medicines with ease. Protect yourself and your loved ones!**
For more updates and detailed official information on the Risperdal 2 mg tablet recall, please visit the [NAFDAC website](https://nafdac.gov.ng/public-alert-no-03-2026-alert-on-the-circulation-of-an-unauthorized-and-unregistered-risperdal-2-mg-tablets-brand-formulation-in-nigeria/). Stay informed. Stay safe.
---
### Summary
This urgent recall of unregistered Risperdal 2 mg tablets reinforces the importance of safe pharmaceutical practices and individual awareness. By taking the right steps and reporting counterfeit medications, we can collectively uphold the safety and health of communities across Nigeria.